In summary, our study provided new insights on diabetes-induced PKCδ activation specifically in EC, which was shown to contribute to the inhibition of VEGFR2 signaling through the increase in SHP-1 phosphatase activity. This evidence concerns the gene KDR and diabetes mellitus.